Haim Bio Co., Ltd.

HaimBio is a pharmaceutical firm that specializes in the development of innovative cancer treatments. Their leading product, Starvanip, is a revolutionary metabolism-based therapy designed to eradicate cancer cells by cutting off their primary energy source. This method not only inhibits cancer cell growth and triggers apoptosis, but also minimizes harmful side effects such as damage to healthy cells and the toxicity associated with traditional chemotherapy. With the potential to treat a broad range of cancers, Starvanip has shown promising results in clinical trials, including a significant reduction in tumor size and increased cancer cell death while preserving the integrity of normal cells.